Bulk Manufacturer of Controlled Substances Application: Stepan Company, 9029 [2018-04269]
Download as PDF
<![CDATA[
9029
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices
institution of this investigation in the
Federal Register on April 29, 2009 (47
FR 19592), and published notice of the
Commission’s invitation to submit
information in connection with the
eighth annual report in the Federal
Register on May 1, 2017 (82 FR 20375).
Written Submissions: Interested
parties are invited to file written
submissions concerning this ninth
annual review. All written submissions
should be addressed to the Secretary,
and all such submissions should be
received no later than 5:15 p.m., April
30, 2018. All written submissions must
conform to the provisions of section
201.8 of the Commission’s Rules of
Practice and Procedure (19 CFR 201.8).
Section 201.8 and the Commission’s
Handbook on Filing Procedures require
that interested parties file documents
electronically on or before the filing
deadline and submit eight (8) true paper
copies by 12:00 p.m. eastern time on the
next business day. If confidential
treatment of a document is requested,
interested parties must file, at the same
time as the eight paper copies, at least
four (4) additional true paper copies in
which the confidential information
must be deleted (see the following
paragraphs for further information
regarding confidential business
information). Persons with questions
regarding electronic filing should
contact the Office of the Secretary,
Docket Services Division (202–205–
1802).
Confidential Business Information.
Any submissions that contain
confidential business information must
also conform to the requirements of
section 201.6 of the Commission’s Rules
of Practice and Procedure (19 CFR
201.6). Section 201.6 of the rules
requires that the cover of the document
and the individual pages be clearly
marked as to whether they are the
‘‘confidential’’ or ‘‘non-confidential’’
version, and that the confidential
business information is clearly
identified by means of brackets. All
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
The Commission will not include any
confidential business information in the
report that it sends to the Committees or
makes available to the public. However,
all information, including confidential
business information, submitted in this
investigation may be disclosed to and
used: (i) By the Commission, its
employees and offices, and contract
personnel (a) for developing or
maintaining the records of this or a
related proceeding, or (b) in internal
investigations, audits, reviews, and
VerDate Sep<11>2014
18:10 Mar 01, 2018
Jkt 244001
evaluations relating to the programs,
personnel, and operations of the
Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government
employees and contract personnel for
cybersecurity purposes. The
Commission will not otherwise disclose
any confidential business information in
a manner that would reveal the
operations of the firm supplying the
information.
Summary of Written Submissions:
The Commission intends to publish a
summary of the written submissions of
interested persons in an appendix to its
report. Persons wishing to have a
summary of their position included in
the appendix should include a summary
with their written submission. The
summary may not exceed 500 words,
should be in MSWord format or a format
that can be easily converted to MSWord,
and should not include any confidential
business information. The summary will
be published as provided if it meets
these requirements and is germane to
the subject matter of the investigation.
In the appendix the Commission will
identify the name of the organization
furnishing the summary, and will
include a link to the Commission’s
Electronic Document Information
System (EDIS) where the full written
submission can be found.
By order of the Commission.
Issued: February 27, 2018.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2018–04308 Filed 3–1–18; 8:45 am]
BILLING CODE 7020–02–P
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Diversion
Control Division (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
22, 2018, Stepan Company, 100 W
Hunter Ave., Maywood, NJ 07607
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Cocaine ..........................
Ecgonine .........................
Drug
code
Schedule
9041
9180
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for sale to its customers. No
other activities for these drug codes are
authorized for this registration.
Dated: February 20, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–04269 Filed 3–1–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF LABOR
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Stepan
Company
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before May 1, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Agreement and Undertaking
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting the Office of
Workers’ Compensation Programs
(OWCP) sponsored information
collection request (ICR) titled,
‘‘Agreement and Undertaking,’’ to the
Office of Management and Budget
(OMB) for review and approval for
continued use, without change, in
accordance with the Paperwork
SUMMARY:
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 83, Number 42 (Friday, March 2, 2018)]
[Notices]
[Page 9029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04269]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Stepan
Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before May 1, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Diversion Control
Division (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
January 22, 2018, Stepan Company, 100 W Hunter Ave., Maywood, NJ 07607
applied to be registered as a bulk manufacturer of the following basic
classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cocaine................................ 9041 II
Ecgonine............................... 9180 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for sale to its customers. No other activities for
these drug codes are authorized for this registration.
Dated: February 20, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-04269 Filed 3-1-18; 8:45 am]
BILLING CODE 4410-09-P
